Allergy Therapeutics plc (AGY.L) LSE

11.25

+0(+0.00%)

Updated at December 24 11:47AM

Currency In GBp

Valuation

Market Cap378.93M
Enterprise Value426.23M
P/E Ratio-13.36
PEG Ratio-2.94
Price/Sales Ratio9.38
Price/Book Ratio-19.02
Enterprise/Revenue10.23
Enterprise/EBITDA-19.14

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.73
Operating Margin-0.53

Management Effectiveness

Return On Assets-0.59
Return On Equity2.27

Income Statement

Revenue55.04M
Revenue/Share0.01
Gross Profit25.13M
EBITDA-29.43M
Net Income-40.13M
Diluted EPS-0.01

Balance Sheet

Total Cash12.79M
Total Cash/Share0
Total Debt60.09M
Total Debt/Equity-2.13
Current Ratio1.28
Book Value Per Share-0.01

Price History

52-Week Change70.97
52-Week High12
52-Week Low5
Moving Average 50 Days9.35
Moving Average 200 Days7.98

Statistics

Average Volume410,699
Shares Outstanding4.59B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor63:29
Last Split DateSeptember 28, 2023